hero section gradient
15 handpicked stocks

Silver Tsunami Solvers

Tap into companies serving the growing senior population's health, housing, and lifestyle needs. These carefully selected stocks represent businesses positioned to benefit from the substantial and increasing purchasing power of older demographics.

Author avatar

Han Tan | Market Analyst

Published on June 18

Your Basket's Financial Footprint

Market capitalisation breakdown for the Silver Tsunami Solvers basket, emphasising the total and distribution across constituent market caps.

Key Takeaways for Investors:
  • Large-cap dominance generally implies greater stability, lower volatility, and closer tracking to broad-market moves.
  • Suitably positioned as a core portfolio holding rather than a speculative, concentrated growth bet.
  • Expect steady, long-term value appreciation rather than rapid, short-term explosive gains.
Total Market Cap
  • HCSG: $1.20B

  • BKD: $2.04B

  • ENSG: $10.57B

  • Other

About This Group of Stocks

1

Our Expert Thinking

We've identified companies benefiting from one of the most reliable demographic trends: global aging. The baby boomer generation and those following represent an enormous market with significant financial resources and non-discretionary spending needs in healthcare, housing, and services.

2

What You Need to Know

These stocks span various industries including senior housing operators, healthcare REITs, home medical equipment, and end-of-life services. They provide exposure to a powerful long-term trend, with many offering dividend income potential alongside growth possibilities.

3

Why These Stocks

Each company was selected for its direct involvement in the senior care ecosystem. We've balanced established market leaders with innovative providers advancing the shift toward home-based care models and telehealth—developments that are expanding the market for senior-focused services.

Why You'll Want to Watch These Stocks

👵

Riding the Age Wave

Baby boomers are entering retirement at a rate of 10,000 per day, creating massive demand for senior-focused services that isn't slowing down anytime soon.

🏠

The Home Care Revolution

New technologies are transforming how seniors receive care, creating exciting investment opportunities in companies enabling the shift to more desirable and cost-effective home-based services.

💰

Recession-Resistant Potential

Many services for seniors are essential and non-discretionary, potentially offering more stability during economic downturns compared to consumer discretionary sectors.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions